Autonomix Medical Debuts CEO Segment on 18-Month Peer-Review Strategy
Autonomix Medical released a new CEO Corner segment where CEO Brad Hauser outlines its 12-to-18-month scientific publication strategy. The segment emphasizes submitting clinical and technical data to competitive, peer-reviewed forums to validate its nerve-targeted catheter technology.
1. CEO Corner Segment Release
Autonomix Medical released its latest CEO Corner segment featuring CEO Brad Hauser, who discusses the company’s strategic efforts to communicate scientific progress. The segment is hosted in the CEO Corner section on the company's website and shared across its social media channels.
2. Focus on Publication Strategy
Hauser detailed a 12-to-18-month initiative to expand the company’s footprint in scientific publications and presentations, highlighting systematic submissions of clinical and technical data to competitive, peer-reviewed forums.
3. Goals of Scientific Validation
The publication strategy is designed to validate Autonomix’s catheter-based microchip sensing array technology, strengthen clinical credibility, and support long-term growth across multiple indications, including pain management and cardiovascular applications.